De Nora India Limited
Momentum (82/100) does the heavy lifting; valuation (13/100) is the drag.
ExpensiveStocksWizard rates De Nora India Limited a Sell, scoring 39/100 on our blended model. On 55.8x trailing earnings it sits pricier than the Industrials median of about 29.0x. The price is about 7% below its 52-week high of ₹949.2 and 55% above the low of ₹567.75. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 2/9. It clears 5 of 11 investability checks, with durability 33, valuation 15 and momentum 82 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹536.38.
1-year price
EOD · 2026-08-0452-week range
-7.29% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell39Piotroski F-score 2/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 7.3%
- No data: Low debt (D/E < 0.5)
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 7%
- No data: Earnings growing
- Fail: Net margin ≥ 10%: 7.4%
- Pass: Current ratio > 1.5: 4.03
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 11.89
- Fail: Piotroski ≥ 7: 2/9
Shareholding
- Promoter58.9%
- Institutions0.8%
- Public & other40.3%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Financially solid — Altman Z 11.89.
Bear case
Weaknesses
- Low return on equity (7.3%).
- Weak Piotroski score (2/9).
Threats
- Rich valuation versus sector peers.
- Trades ~24% above our estimated fair value.
About De Nora India Limited
De Nora India Limited manufactures and services electrolytic products including anodes for chlorine and oxygen evolution, cathodes for hydrogen evolution, disinfection systems, electrodes for metal winning, cathodic protection components, membrane technologies, and water treatment products. The company operates in India and internationally, providing manufacturing and recoating services for anodes and cathodes used in chlor-alkali processes.
De Nora India Limited — frequently asked questions
Is De Nora India Limited a buy, hold or sell?
StocksWizard currently rates De Nora India Limited (DENORA) a Sell, based on a blended score of 39/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is De Nora India Limited's fair value?
Our blended DCF and relative-valuation model estimates De Nora India Limited's fair value at about ₹670.47, versus a current price of ₹880.05 — roughly 24% downside. On that basis the stock looks overvalued by 24%.
Is De Nora India Limited financially healthy?
De Nora India Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 2/9.
How has De Nora India Limited's share price performed?
De Nora India Limited is up 16% over three months, and last traded at ₹880.05. Past performance doesn't predict future returns.
More in Industrials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.